Examining the effects of active esophageal cooling during atrial fibrillation ablation
Official title: REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-study of the REAL AF Registry
Run by Heart Rhythm Clinical and Research Solutions, LLC · NCT06354777 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if using active cooling on the esophagus during heart ablation can help people with atrial fibrillation have safer and more effective procedures.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 312 (estimated) |
| Sponsor | Heart Rhythm Clinical and Research Solutions, LLC Academic / other |
| Locations | 5 sites (Chandler, Arizona and 4 other locations) |
| Trial ID | NCT06354777 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults over 18 with symptomatic Paroxysmal or Persistent Atrial Fibrillation scheduled for ablation.
✕Probably not a fit
Patients under 18 or those with contraindications to ablation procedures will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational sub-study investigates the effectiveness of active esophageal cooling in patients undergoing left atrial ablation for symptomatic Paroxysmal or Persistent Atrial Fibrillation. The study aims to assess the impact of this cooling technique on reducing risks to the esophagus and improving overall procedural outcomes. By analyzing data from multiple centers, the research seeks to clarify the benefits of active cooling, including potential reductions in procedure time and post-ablation discomfort, while ensuring patient safety. Participants will be enrolled from the REAL AF Registry and will undergo a thorough evaluation to determine eligibility.
Why it matters
Potential benefit: If successful, this approach could lead to safer and more effective atrial fibrillation ablation procedures with fewer complications.
How similar studies have gone: Previous studies, including the IMPACT trial, have shown promising results with similar approaches, indicating potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Symptomatic Paroxysmal Atrial Fibrillation (AF episode terminate spontaneously within 7 days) or Persistent Atrial Fibrillation (AF sustained beyond 7 days) who, in the opinion of the investigator, are scheduled for ablation for Atrial Fibrillation with active esophageal cooling. * \>18 years of age * Index or redo ablation procedure and enrolled in the REAL AF Registry * Willing and able to provide informed consent and complete GERD questionnaire. Exclusion Criteria: * For the purpose of this sub-study, candidates will be excluded if they meet any of the following criteria: * Enrolled in an investigational drug or device clinical trial, or any trial that dictates the treatment plan. * In the opinion of the investigator, any known contraindication to an ablation procedure. * \<18 years of age
Where it's running
-
Valley Heart Rhythm Specialists
Chandler, Arizona, United States Recruiting -
Ascension St. Vincent Hospital Indianapolis
Indianapolis, Indiana, United States Recruiting -
Christ Hospital
Cincinnati, Ohio, United States Recruiting -
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States Recruiting -
MultiCare Institute for Research & Innovation
Tacoma, Washington, United States Recruiting
Study contacts
- Study coordinator: Carla Perna
- Email: cperna@hrcrs.com
- Phone: 205-223-0960
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities
This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.
-
Dual Energy ablation with SmartTouch SF catheter in persistent atrial fibrillation
This study tests a pulsed field and radiofrequency ablation system to treat persistent atrial fibrillation in adults who have not responded well to prior medications.
-
Identifying AF patients who may need more than standard ablation using Volta AF-Xplorer II
This trial tests whether AI-identified dispersion areas during AF ablation can predict recurrence after a standard pulmonary vein isolation in patients with persistent AF.
-
4D intracardiac echocardiography to guide left atrial appendage occlusion procedures
A new 4D ICE catheter is being tested alongside standard imaging to see if it can safely guide left atrial appendage occlusion procedures for adults with atrial fibrillation.
-
Thoracoscopic vs Catheter Ablation as the First Rhythm Control in Atrial Fibrillation with a Large Left Atrium
This trial tests whether thoracoscopic surgical ablation is better at keeping atrial fibrillation under control than catheter ablation in people with persistent AF and a large left atrium who have not had an ablation before.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.